Detection of cerebrospinal fluid leukemia cells in the diagnosis of leukemia by flow cytometry / 中国基层医药

ABSTRACT

Objective To investigate the application and clinical significance of flow cytometry(FCM)in cerebrospinal fluid(CSF)detection in the diagnosis of central nervous system leukemia(CNSL).Methods By the CD34,CD45 based different monoclonal antibody combined FCM detection method,CSF of 100 patients with CNSL was detected multi parameter of minimal residual disease(MRD).And with the natural sedimentation of cerebrospinal fluid after smear method,CSF cytology results were compared and analyzed.Results Of the 100 patients,CSF exami-nation was positive in 42 patients.CSF cytology was positive in 16 cases,the difference was statistically significant (χ2 =4.19,P <0.05).10 cases of nervous system symptoms of CSF examination were positive,and only 5 cases of CSF cytology positive(χ2 =6.81,P =0.018).In 100 cases of MRD detection,18 cases increased in white blood cell count,FMC detected in 17 cases,cytological diagnosis of 11 cases (χ2 =5.89,P =0.024).CSF with elevated pres-sure in 11 patients,FCMpositive in 11 cases,cytology detected in 4 cases(χ2 =5.12,P =0.031).CSF protein was elevated in 19 cases,FCMdetected 17 cases,cytology detected 7 cases(χ2 =7.14,P =0.001).Conclusion FCM combined with routine CSF detection can improve the positive rate of CNSL diagnosis,and it has important significance for early detection and treatment of CNSL,and to prolong the disease -free survival of patients with leukemia.